title: [Mass screening for prostate cancer is the best approach to early diagnosis and treatment of prostate cancer].
abstract: To achieve the goal of early detection, diagnosis and treatment of prostate cancer in China, mass screening for prostate cancer using serum prostate specific antigen (PSA) has been performed in men over 50 years. We compared this result with the clinical cases. It proved that only through the mass screening can we really find the early stage prostate cancer and be given the chance of curing the cancer. We also investigated the current treatment situation and problems and figured out the further direction on the prostate cancer research.
authors.affiliation: Prostate Diseases Prevention and Treatment Research Centre, Jilin University, Changchun, Jilin 130021, China.
authors.forename: Xue-Jian
authors.initials: XJ
authors.lastname: Zhao
authors.forename: Xiang-Bo
authors.initials: XB
authors.lastname: Kong
authors.forename: Wei-Hua
authors.initials: WH
authors.lastname: Wang
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D002681:China / Q000453:epidemiology; D042241:Early Diagnosis; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen